Moreover, significant differences in semiquantitative HDAC2 expression were identified between groups G1 and G3 (p=0.007) and G1 and G4 (p=0.035), indicating lower HDAC2 expression in mammary carcinomas relative to normal tissue. This evidence concerns the gene HDAC2 and breast carcinoma.